Merger Notification - Announcement according to § 10 Cartel Act
Becton, Dickinson and Company; Geschäftsbereich Intensivmedizin von Edwards Lifesciences Corporation
BWB/Z-6622
On 17.06.2024 the Austrian Federal Competition Authority was notified of the following merger:
Planned purchase process
Becton, Dickinson and Company (USA) intends to acquire the Critical Care business of Edwards Lifesciences Corporation (USA).
The transaction concerns medical devices for use in a critical care environment.
ÖNACE-code: Manufacture of medical and dental instruments and supplies.
C - MANUFACTURING
Deadline for bringing in an application pursuant to § 11(1) Cartel Act will end on 15.07.2024.
Entrepreneurs whose legal or economic interests are affected by the merger can bring in a written statement at the Federal Competition Authority or the Federal Cartel Prosecutor within 14 days from publication date.
Note: The intervening party has no right to a certain treatment of the statement and will not gain a party position.
Non-prohibition of the merger
The Federal Competition Authority and the Federal Cartel Prosecutor have not applied for examination of the merger by the Cartel Court. The standstill obligation (§ 17 (1) Cartel Act) ends with effect from 16.07.2024 .